Kanker Payudara

Bridging the Global Knowledge Divide: Research4Life Marks 25 Years of Democratizing Science

• Breast Cancer Prevention and Lifestyle

Bridging the Global Knowledge Divide: Research4Life Marks 25 Years of Democratizing Science

Evan Lee Salim July 30, 2026

Introduction: A Quarter-Century of Equitable Access In an era where scientific advancement is the bedrock of global...

Read More Read more about Bridging the Global Knowledge Divide: Research4Life Marks 25 Years of Democratizing Science

A Tapestry of Hope: From Personal Loss to a Beacon of Early Detection

• Patient Advocacy and Support

A Tapestry of Hope: From Personal Loss to a Beacon of Early Detection

Ammar Sabilarrohman July 30, 2026

By Cynthia Lohr A 17-Year Partner of the National Breast Cancer Foundation Publish Date: February 3, 2026...

Read More Read more about A Tapestry of Hope: From Personal Loss to a Beacon of Early Detection

Fragile Gains: The Global Struggle Against Hunger and Malnutrition in 2026

• Global Breast Cancer Awareness

Fragile Gains: The Global Struggle Against Hunger and Malnutrition in 2026

Evan Lee Salim July 30, 2026

By International Affairs Desk Global hunger has retreated for the third consecutive year, offering a glimmer of...

Read More Read more about Fragile Gains: The Global Struggle Against Hunger and Malnutrition in 2026

Advancing Precision Cardiology: Dr. Walter’s Strategic Move to Bayer and the Broad Institute

• Genomics and Precision Medicine

Advancing Precision Cardiology: Dr. Walter’s Strategic Move to Bayer and the Broad Institute

Evan Lee Salim July 30, 2026

Main Facts: A New Chapter in Cardiovascular Innovation In a significant development for the field of cardiovascular...

Read More Read more about Advancing Precision Cardiology: Dr. Walter’s Strategic Move to Bayer and the Broad Institute

Ending the Diagnostic Odyssey: Can Early Exome Sequencing Revolutionize Outpatient Care?

• Genomics and Precision Medicine

Ending the Diagnostic Odyssey: Can Early Exome Sequencing Revolutionize Outpatient Care?

Dwi Wanna July 30, 2026

In the rapidly shifting landscape of clinical genomics, the journey for patients with undiagnosed rare diseases is...

Read More Read more about Ending the Diagnostic Odyssey: Can Early Exome Sequencing Revolutionize Outpatient Care?

Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Journey Through Breast Cancer

• Survivorship and Post-Treatment

Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Journey Through Breast Cancer

Lina Hope July 30, 2026

For 47-year-old Shelly, the month of May 2024 began with the mundane rhythms of daily life. Married...

Read More Read more about Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Journey Through Breast Cancer

EMA Taps TrialAssure for Clinical Trial Data Anonymization Amidst Evolving Data Protection Landscape

• Medical Research and Clinical Trials

EMA Taps TrialAssure for Clinical Trial Data Anonymization Amidst Evolving Data Protection Landscape

Ammar Sabilarrohman July 30, 2026

The European Medicines Agency (EMA) has officially designated TrialAssure’s ANONYMIZE platform as its go-to tool for clinical...

Read More Read more about EMA Taps TrialAssure for Clinical Trial Data Anonymization Amidst Evolving Data Protection Landscape

Targeted Breakthrough: Casdatifan Offers New Hope for Advanced Kidney Cancer Patients

• Clinical Oncology Education

Targeted Breakthrough: Casdatifan Offers New Hope for Advanced Kidney Cancer Patients

Layla Zulfa July 30, 2026

In the landscape of oncology, clear cell renal cell carcinoma (ccRCC) has long been regarded as a...

Read More Read more about Targeted Breakthrough: Casdatifan Offers New Hope for Advanced Kidney Cancer Patients

Weekly Oral HIV Regimen: Gilead and Merck’s New Frontier in Antiretroviral Therapy

• Chemotherapy and Targeted Therapy

Weekly Oral HIV Regimen: Gilead and Merck’s New Frontier in Antiretroviral Therapy

Ammar Sabilarrohman July 30, 2026

In a potential paradigm shift for HIV management, pharmaceutical giants Gilead Sciences and Merck have unveiled promising...

Read More Read more about Weekly Oral HIV Regimen: Gilead and Merck’s New Frontier in Antiretroviral Therapy

From Campus Philanthropy to Personal Lifeline: A Journey of Advocacy and Resilience with Team Sharsheret

• Survivorship and Post-Treatment

From Campus Philanthropy to Personal Lifeline: A Journey of Advocacy and Resilience with Team Sharsheret

Sagoh July 30, 2026

By [Your Name/Editorial Desk] July 29, 2026 For many college students, sorority philanthropy is a meaningful but...

Read More Read more about From Campus Philanthropy to Personal Lifeline: A Journey of Advocacy and Resilience with Team Sharsheret